Home/Filings/4/0001209191-21-059375
4//SEC Filing

Keen Nicholas 4

Accession 0001209191-21-059375

CIK 0001761612other

Filed

Oct 4, 8:00 PM ET

Accepted

Oct 5, 4:16 PM ET

Size

6.8 KB

Accession

0001209191-21-059375

Insider Transaction Report

Form 4
Period: 2021-10-01
Keen Nicholas
Chief Scientific Officer
Transactions
  • Sale

    Ordinary Shares

    2021-10-05$45.10/sh2,178$98,2280 total
  • Sale

    Ordinary Shares

    2021-10-01$45.00/sh1,188$53,4602,178 total
Footnotes (2)
  • [F1]Shares were sold pursuant to a Rule 10b5-1 trading plan.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $45.52 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Issuer

BICYCLE THERAPEUTICS plc

CIK 0001761612

Entity typeother

Related Parties

1
  • filerCIK 0001776881

Filing Metadata

Form type
4
Filed
Oct 4, 8:00 PM ET
Accepted
Oct 5, 4:16 PM ET
Size
6.8 KB